KLSE · Healthcare

PeterLabs Holdings Bhd (0171)

Drug Manufacturers - Specialty & Generic

PeterLabs Holdings Bhd (0171) is listed on KLSE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 0171

P/E ratio

18.00

PeterLabs Holdings Bhd (0171) — FAQ

What is 0171's P/E ratio?

The price-to-earnings (P/E) ratio for PeterLabs Holdings Bhd (0171) is 18.00 (data as of 2026-05-24).

Does PeterLabs Holdings Bhd pay a dividend?

Dividend yield is not available in the current snapshot for PeterLabs Holdings Bhd (0171). Check the MyAverix Finance app for the latest dividend data.

What sector is PeterLabs Holdings Bhd in?

PeterLabs Holdings Bhd (0171) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 0171 listed on?

0171 is listed on KLSE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)